Phase I Study to Determine the Safety of E7070 in Patients With a Solid Tumor on a Single IV Infusion Repeated Every 3 Weeks.
Phase of Trial: Phase I
Latest Information Update: 22 Jun 2013
At a glance
- Drugs Indisulam (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 10 Jul 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Oct 2005 New trial record.